How would you approach patients with primary cardiac sarcomas for adjuvant systemic treatment?

Topics: Radiation Oncology • Pediatric Oncology • Sarcoma • Medical Oncology

How do we approach patients with rare tumors given the paucity of data?

Answer from: Medical Oncologist at Academic Institution

Majority of these primary cardiac sarcomas tend to be angiosarcomas or UPS-variants. They inherently have a poor prognosis with high risk of metastases and death. Adjuvant XRT is generally difficult in this location. These also generally affect young individuals with o/w good PS/organ function. So w...

Comments

Medical Oncologist at University of Utah
Thank you - my particular patient has a high grade...

Medical Oncologist at University Hospitals
We published a case report for a patient with card...

Answer from: Medical Oncologist at Community Practice

I agree with Dr. @Patel. I would also test the sarcoma for genomics.

Comments

Medical Oncologist at University of Utah
Despite the age, you’d proceed with AIM? Th...

Medical Oncologist at Rutgers Cancer Institute of New Jersey
I would not do ifosfamide in a patient in their 70...

Medical Oncologist at University of Utah
Thank you

Related Questions